SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002442
Filing Date
2020-04-20
Accepted
2020-04-20 16:20:49
Documents
11
Period of Report
2020-05-19
Effectiveness Date
2020-04-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241426zdef14a.htm DEF 14A 5679990
2 G824088.JPG g824088.jpg GRAPHIC 5956
3 G799245.JPG g799245.jpg GRAPHIC 10566
4 G117931.JPG g117931.jpg GRAPHIC 72345
5 G89634.JPG g89634.jpg GRAPHIC 7604
6 G209280.JPG g209280.jpg GRAPHIC 13644
7 G438531.JPG g438531.jpg GRAPHIC 6639
8 G188851.JPG g188851.jpg GRAPHIC 4638
9 G331630.JPG g331630.jpg GRAPHIC 10634
10 G148002MMI001.GIF g148002mmi001.gif GRAPHIC 263037
11 G148002MMI002.JPG g148002mmi002.jpg GRAPHIC 173899
  Complete submission text file 0001047469-20-002442.txt   6465887
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-13111 | Film No.: 20802762
SIC: 2834 Pharmaceutical Preparations